Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...

The process of drug discovery encompasses a variety of methods, including experimental, computational, translational, and clinical.  When successful, | Cancer ...

Today, MALDI-ToF MS is an established technique to characterize and identify pathogenic bacteria. The technique is increasingly applied by clinical microbiological laboratories that use commercially ...

This protocol describes a standardized workflow for multiplexed charge detection mass spectrometry (CDMS) on an Orbitrap analyzer. This allows individual ion mass spectrometry to be performed on a ...

Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

Just how far mass spectrometry—the use of tools measuring the mass-to-charge ratio (m/z) of one or more molecules present in a sample—has progressed over the past century can be seen in a new exhibit ...

A tool developed by IU professors is on the market and foreseeing developments in gene therapy, environmental science and more. One month into its commercial launch, the Xevo Charge Detection Mass ...

Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is seeing all the molecules in an intact tissue sample, down to the level of ...